$CFBK
CF BANKSHARES INC. Stock $cfbk

$cfbk Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000107068020000017 Filed on May 13, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$9.946M	$7.941M
YoY Change	25.25%	55.58%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$86.00K	$71.00K
YoY Change	21.13%	20.34%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$3.823M	$2.841M
YoY Change	34.57%	138.14%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$2.523M	$2.100M
YoY Change	20.14%	114.72%
Income Tax	$517.0K	$419.0K
% Of Pretax Income	20.49%	19.95%
Net Earnings	$2.006M	$1.681M
YoY Change	19.33%	112.25%
Net Earnings / Revenue	20.17%	21.17%
Basic Earnings Per Share	$0.31	$0.39
Diluted Earnings Per Share	$0.30	$0.39
COMMON SHARES
Basic Shares Outstanding	5.334M	4.356M
Diluted Shares Outstanding	5.400M	4.418M

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$75.35M	$95.99M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$4.040M	$3.875M
YoY Change	4.26%	7.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$945.4M	$720.5M
YoY Change	31.21%	35.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.10M	$5.100M
YoY Change	176.47%	75.86%
Accrued Expenses	$1.900M	$2.300M
YoY Change	-17.39%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$16.00M	$7.400M
YoY Change	116.22%	155.17%
LONG-TERM LIABILITIES
Long-Term Debt	$14.80M	$14.80M
YoY Change	0.0%	184.62%
Other Long-Term Liabilities	$600.0K	$400.0K
YoY Change	50.0%	100.0%
Total Long-Term Liabilities	$15.40M	$15.20M
YoY Change	1.32%	181.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.00M	$7.400M
Total Long-Term Liabilities	$15.40M	$15.20M
Total Liabilities	$862.5M	$672.8M
YoY Change	28.18%	37.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$926.0K	-$11.05M
YoY Change	-91.62%
Common Stock	$54.00K	$44.00K
YoY Change	22.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.465M	$3.366M
YoY Change	2.94%
Treasury Stock Shares	$39.56K	$31.24K
Shareholders Equity	$82.88M	$47.63M
YoY Change
Total Liabilities & Shareholders Equity	$945.4M	$720.5M
YoY Change	31.21%	35.97%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	$2.006M	$1.681M
YoY Change	19.33%	112.25%
Depreciation, Depletion And Amortization	$86.00K	$71.00K
YoY Change	21.13%	20.34%
Cash From Operating Activities	$34.95M	-$8.366M
YoY Change	-517.75%	16.73%
INVESTING ACTIVITIES
Capital Expenditures	$135.0K	$82.00K
YoY Change	64.63%	-42.25%
Acquisitions
YoY Change
Other Investing Activities	-$47.50M	-$13.70M
YoY Change	246.72%	-12.18%
Cash From Investing Activities	-$47.66M	-$13.80M
YoY Change	245.34%	-12.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	42.19M	50.86M
YoY Change	-17.05%	6.46%
NET CHANGE
Cash From Operating Activities	34.95M	-8.366M
Cash From Investing Activities	-47.66M	-13.80M
Cash From Financing Activities	42.19M	50.86M
Net Change In Cash	29.47M	28.69M
YoY Change	2.73%	15.23%
FREE CASH FLOW
Cash From Operating Activities	$34.95M	-$8.366M
Capital Expenditures	$135.0K	$82.00K
Free Cash Flow	$34.81M	-$8.448M
YoY Change	-512.1%	15.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q4	cfbk	Advances From Federal Home Loan Banks And Other Debt AdvancesFromFederalHomeLoanBanksAndOtherDebt	29017000
CY2020Q1	cfbk	Advances From Federal Home Loan Banks And Other Debt AdvancesFromFederalHomeLoanBanksAndOtherDebt	82594000
CY2019Q4	cfbk	Allocated Specific Reserves To Modified Tdrs AllocatedSpecificReservesToModifiedTdrs	22000
CY2020Q1	cfbk	Allocated Specific Reserves To Modified Tdrs AllocatedSpecificReservesToModifiedTdrs	21000
CY2016Q1	cfbk	Capital Conservation Buffer CapitalConservationBuffer	0.00625
CY2019Q1	cfbk	Capital Conservation Buffer CapitalConservationBuffer	0.025
CY2016Q1	cfbk	Capital Conservative Buffer Phase Period CapitalConservativeBufferPhasePeriod	P4Y
CY2019Q1	cfbk	Change In Fair Value ChangeInFairValue	475000
CY2020Q1	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	58000
CY2019Q1	us-gaap	Taxes Other TaxesOther	106000
CY2020Q1	us-gaap	Taxes Other TaxesOther	179000
CY2019Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	87857000
CY2020Q1	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	95418000
CY2019Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	33221000
CY2020Q1	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	35754000
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	663303000
CY2020Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	707868000
CY2020Q1	cfbk	Change In Fair Value ChangeInFairValue	2432000
CY2019Q1	cfbk	Common Equity Tier1 Capital To Risk Weighted Assets Ratio CommonEquityTier1CapitalToRiskWeightedAssetsRatio	0.045
CY2019Q1	cfbk	Common Equity Tier1 Capital To Risk Weighted Assets Upon Full Implementation Ratio CommonEquityTier1CapitalToRiskWeightedAssetsUponFullImplementationRatio	0.070
CY2019Q4	cfbk	Common Equity Tier One Risk Based Capital CommonEquityTierOneRiskBasedCapital	87857000
CY2020Q1	cfbk	Common Equity Tier One Risk Based Capital CommonEquityTierOneRiskBasedCapital	95418000
CY2019Q4	cfbk	Common Equity Tier One Risk Based Capital Required For Capital Adequacy CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacy	51398000
CY2020Q1	cfbk	Common Equity Tier One Risk Based Capital Required For Capital Adequacy CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacy	54349000
CY2019Q4	cfbk	Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.0700
CY2020Q1	cfbk	Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.0700
CY2019Q4	cfbk	Common Equity Tier One Risk Based Capital Required To Be Well Capitalized CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalized	47726000
CY2020Q1	cfbk	Common Equity Tier One Risk Based Capital Required To Be Well Capitalized CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalized	50467000
CY2019Q4	cfbk	Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.0650
CY2020Q1	cfbk	Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.0650
CY2019Q4	cfbk	Common Equity Tier One Risk Based Capital To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalToRiskWeightedAssets	0.1197
CY2020Q1	cfbk	Common Equity Tier One Risk Based Capital To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalToRiskWeightedAssets	0.1229
CY2020Q1	cfbk	Deferred Tax Assets Operating Loss Carryforwards That Will Expire Unutilized Federal DeferredTaxAssetsOperatingLossCarryforwardsThatWillExpireUnutilizedFederal	20520000
CY2019Q1	cfbk	Dilutive Effect Of Employee Stock Options Shares Used In Computation DilutiveEffectOfEmployeeStockOptionsSharesUsedInComputation	39073
CY2020Q1	cfbk	Dilutive Effect Of Employee Stock Options Shares Used In Computation DilutiveEffectOfEmployeeStockOptionsSharesUsedInComputation	26421
CY2019Q4	cfbk	Fair Value Assets And Liabilities Transfer Level1 To Level3 FairValueAssetsAndLiabilitiesTransferLevel1ToLevel3	0
CY2020Q1	cfbk	Fair Value Assets And Liabilities Transfer Level1 To Level3 FairValueAssetsAndLiabilitiesTransferLevel1ToLevel3	0
CY2019Q4	cfbk	Fair Value Assets And Liabilities Transfer Level3 To Level1 FairValueAssetsAndLiabilitiesTransferLevel3ToLevel1	0
CY2020Q1	cfbk	Fair Value Assets And Liabilities Transfer Level3 To Level1 FairValueAssetsAndLiabilitiesTransferLevel3ToLevel1	0
CY2019Q4	cfbk	Financing Receivable Recorded Investment Nonaccrual Loans Not90 Days Past Due FinancingReceivableRecordedInvestmentNonaccrualLoansNot90DaysPastDue	302000
CY2020Q1	cfbk	Financing Receivable Recorded Investment Nonaccrual Loans Not90 Days Past Due FinancingReceivableRecordedInvestmentNonaccrualLoansNot90DaysPastDue	248000
CY2019Q1	cfbk	Foreclosed Assets Net ForeclosedAssetsNet	-9000
CY2019Q1	cfbk	Future Percent Common Equity Of Risk Weighted Assets FuturePercentCommonEquityOfRiskWeightedAssets	0.025
CY2019Q1	cfbk	Gain Loss On Loans Held For Sale GainLossOnLoansHeldForSale	261000
CY2020Q1	cfbk	Gain Loss On Loans Held For Sale GainLossOnLoansHeldForSale	1235000
CY2019Q1	cfbk	Gain On Sale Of Foreclosed Assets GainOnSaleOfForeclosedAssets	12000
CY2019Q4	cfbk	Impaired Financing Receivable Allocated Allowance Loans And Leases ImpairedFinancingReceivableAllocatedAllowanceLoansAndLeases	35000
CY2020Q1	cfbk	Impaired Financing Receivable Allocated Allowance Loans And Leases ImpairedFinancingReceivableAllocatedAllowanceLoansAndLeases	21000
CY2019Q1	cfbk	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	127000
CY2020Q1	cfbk	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	95000
CY2019Q1	cfbk	Increase Decrease In Operating Lease Right Of Use Liability IncreaseDecreaseInOperatingLeaseRightOfUseLiability	107000
CY2020Q1	cfbk	Increase Decrease In Operating Lease Right Of Use Liability IncreaseDecreaseInOperatingLeaseRightOfUseLiability	104000
CY2019Q4	cfbk	Interest Bearing Deposits In Other Financial Institutions InterestBearingDepositsInOtherFinancialInstitutions	100000
CY2020Q1	cfbk	Interest Bearing Deposits In Other Financial Institutions InterestBearingDepositsInOtherFinancialInstitutions	100000
CY2019Q1	cfbk	Interest Expense Loans And Leases Heldforsale InterestExpenseLoansAndLeasesHeldforsale
CY2020Q1	cfbk	Interest Expense Loans And Leases Heldforsale InterestExpenseLoansAndLeasesHeldforsale
CY2020Q1	cfbk	Lessee Operating Lease Term LesseeOperatingLeaseTerm	2024
CY2020Q1	cfbk	Loans Held For Sale Funded With Other Debt LoansHeldForSaleFundedWithOtherDebt	13202000
CY2019Q1	cfbk	Loans Modified Not Troubled Debt Restructurings Recorded Investment LoansModifiedNotTroubledDebtRestructuringsRecordedInvestment	5183000
CY2020Q1	cfbk	Loans Modified Not Troubled Debt Restructurings Recorded Investment LoansModifiedNotTroubledDebtRestructuringsRecordedInvestment	17295000
CY2019Q1	cfbk	Minimum Leverage Ratio Based On Required Basel3 Rules MinimumLeverageRatioBasedOnRequiredBasel3Rules	0.040
CY2020Q1	cfbk	Minimum Outstanding Impaired Commercial Loans MinimumOutstandingImpairedCommercialLoans	250000
CY2019Q4	cfbk	Mortgage Servicing Rights Msr Valuation Allowances MortgageServicingRightsMsrValuationAllowances	35000
CY2019Q1	cfbk	Noncash Initial Recognition Of Operating Right Of Use Lease Asset NoncashInitialRecognitionOfOperatingRightOfUseLeaseAsset	2368000
CY2019Q1	cfbk	Noncash Initial Recognition Of Operating Right Of Use Lease Liability NoncashInitialRecognitionOfOperatingRightOfUseLeaseLiability	2368000
CY2020Q1	cfbk	Number Of Stock Based Compensation Plans NumberOfStockBasedCompensationPlans	2
CY2020Q1	cfbk	Opening Balance In Liquidation Account OpeningBalanceInLiquidationAccount	14300000
CY2020Q1	cfbk	Operating Leases Future Minimum Undiscounted Excess Amount OperatingLeasesFutureMinimumUndiscountedExcessAmount	264000
CY2020Q1	cfbk	Operating Loss Carryforwards Limitations On Use Amount OperatingLossCarryforwardsLimitationsOnUseAmount	163000
CY2019Q1	cfbk	Other Insurance OtherInsurance	23000
CY2020Q1	cfbk	Other Insurance OtherInsurance	27000
CY2019Q4	cfbk	Pledged Assets Separately Reported Securities Pledged For Interest Rate Swaps At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedForInterestRateSwapsAtFairValue	77000
CY2020Q1	cfbk	Pledged Assets Separately Reported Securities Pledged For Interest Rate Swaps At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedForInterestRateSwapsAtFairValue	70000
CY2019Q4	cfbk	Pledged Assets Separately Reported Securities Pledged For Public Deposits At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedForPublicDepositsAtFairValue	2015000
CY2020Q1	cfbk	Pledged Assets Separately Reported Securities Pledged For Public Deposits At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedForPublicDepositsAtFairValue	2565000
CY2019Q1	cfbk	Regulatory Assessment RegulatoryAssessment	42000
CY2020Q1	cfbk	Regulatory Assessment RegulatoryAssessment	45000
CY2020Q1	cfbk	Swap Fee Income SwapFeeIncome	393000
CY2019Q1	cfbk	Tier1 Capital To Risk Weighted Assets Ratio Tier1CapitalToRiskWeightedAssetsRatio	0.060
CY2019Q1	cfbk	Tier1 Capital To Risk Weighted Assets Upon Full Implementation Ratio Tier1CapitalToRiskWeightedAssetsUponFullImplementationRatio	0.085
CY2019Q1	cfbk	Total Capital To Risk Weighted Assets Ratio TotalCapitalToRiskWeightedAssetsRatio	0.080
CY2019Q1	cfbk	Total Capital To Risk Weighted Assets Upon Full Implementation Ratio TotalCapitalToRiskWeightedAssetsUponFullImplementationRatio	0.105
CY2019Q1	cfbk	Transfer Of Other Liability To Operating Lease Right Of Use Asset TransferOfOtherLiabilityToOperatingLeaseRightOfUseAsset	184000
CY2020Q1	cfbk	Treasury Stock Value Acquisition Surrendered For Payment Of Taxes TreasuryStockValueAcquisitionSurrenderedForPaymentOfTaxes	27000
CY2019Q4	cfbk	Unpaid Principal Balance Of Impaired Loans Carried At Fair Value Of Collateral UnpaidPrincipalBalanceOfImpairedLoansCarriedAtFairValueOfCollateral	4612000
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	City Area Code CityAreaCode	614
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	7000 North High St.
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Worthington
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	43085
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001070680
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5316573
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	CENTRAL FEDERAL CORP
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	34-1877137
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	334-7979
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock, $.01 par value
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q1	dei	Trading Symbol TradingSymbol	cfbk
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6846000
CY2020Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	14078000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	28000
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	172000
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities	0
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities	0
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	86903000
CY2020Q1	us-gaap	Capital Capital	102688000
CY2019Q4	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	77097000
CY2020Q1	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	81524000
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	87046000
CY2019Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	-44000
CY2020Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	-159000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	116000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	143000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	243000
CY2019Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	929000
CY2020Q1	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	636000
CY2019Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs
CY2020Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	71000
CY2019Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	12000
CY2020Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	6000
CY2019Q4	us-gaap	Assets Assets	880545000
CY2020Q1	us-gaap	Assets Assets	945365000
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	8174000
CY2020Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	11390000
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	36000
CY2020Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	218000
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000
CY2019Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	8139000
CY2020Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	11172000
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1000
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	1000
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	3000000
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	499000
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	2501000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2985000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	6537000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3017000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	6704000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	5001000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	4500000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	5000000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	4546000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	8174000
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	11390000
CY2019Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	5345000
CY2020Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	5381000
CY2019Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	34000
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	36000
CY2019Q4	us-gaap	Capital Capital	95164000
CY2019Q4	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.1050
CY2020Q1	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.1050
CY2019Q4	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	73425000
CY2020Q1	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	77642000
CY2019Q4	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.1000
CY2020Q1	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.1000
CY2019Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1296
CY2020Q1	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1323
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67304000
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	95993000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45879000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75352000
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	28689000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	29473000
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	272727
CY2003Q4	us-gaap	Common Stock Held In Trust CommonStockHeldInTrust	155000
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9090909
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9090909
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5409394
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5377160
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	54000
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	54000
CY2019Q1	us-gaap	Communication Communication	45000
CY2020Q1	us-gaap	Communication Communication	54000
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1716000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2150000
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8000
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-38000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1700000
CY2020Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1600000
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0
CY2019Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Policyholders Surplus DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus	473000
CY2019Q4	us-gaap	Deposits Deposits	746323000
CY2020Q1	us-gaap	Deposits Deposits	748505000
CY2019Q1	us-gaap	Depreciation Depreciation	71000
CY2020Q1	us-gaap	Depreciation Depreciation	86000
CY2019Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	71000
CY2020Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	86000
CY2019Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-41000
CY2020Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3973000
CY2019Q4	us-gaap	Direct Financing Lease Deferred Selling Profit DirectFinancingLeaseDeferredSellingProfit	473000
CY2020Q1	us-gaap	Direct Financing Lease Deferred Selling Profit DirectFinancingLeaseDeferredSellingProfit	435000
CY2019Q4	us-gaap	Direct Financing Lease Lease Receivable DirectFinancingLeaseLeaseReceivable	5252000
CY2020Q1	us-gaap	Direct Financing Lease Lease Receivable DirectFinancingLeaseLeaseReceivable	5054000
CY2019Q4	us-gaap	Direct Financing Lease Net Investment In Lease DirectFinancingLeaseNetInvestmentInLease	4779000
CY2020Q1	us-gaap	Direct Financing Lease Net Investment In Lease DirectFinancingLeaseNetInvestmentInLease	4619000
CY2019Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	54000
CY2020Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	44000
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.200
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.205
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.001
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.002
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.007
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.011
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.003
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.003
CY2019Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	24000
CY2020Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	30000
CY2019Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	261000
CY2020Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	1235000
CY2019Q4	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due FairValueOptionLoansHeldAsAssets90DaysOrMorePastDue	0
CY2020Q1	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due FairValueOptionLoansHeldAsAssets90DaysOrMorePastDue	0
CY2019Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	152000
CY2020Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	157000
CY2019Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	29017000
CY2020Q1	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	82594000
CY2019Q4	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	4008000
CY2020Q1	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	4510000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	7103000
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	7052000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	35000
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	21000
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0
CY2019Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	665829000
CY2020Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	711978000
CY2019Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	4612000
CY2020Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	2963000
CY2019Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2020Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	2923000
CY2020Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	2924000
CY2019Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
CY2020Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
CY2019Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
CY2020Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	665215000
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	712266000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	2439000
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	696000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	5226000
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	2675000
CY2019Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	1232000
CY2020Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	5582000
CY2019Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1503000
CY2020Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	2844000
CY2019Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	3712000
CY2020Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	2984000
CY2019Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	44000
CY2020Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	41000
CY2019Q1	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	46000
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	4612000
CY2020Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	2963000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	35000
CY2020Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	21000
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	4612000
CY2020Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	2963000
CY2019Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	123000
CY2019Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	5000
CY2019Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	3589000
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	2984000
CY2019Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	39000
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	41000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	4612000
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	2963000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	4612000
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	2963000
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2100000
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2523000
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	419000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	517000
CY2020Q1	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	2250000
CY2019Q1	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	-429000
CY2020Q1	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	-293000
CY2019Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	52043000
CY2020Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	2182000
CY2019Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	712000
CY2020Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	7232000
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	991000
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	6588000
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	22954
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	39950
CY2019Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	316000
CY2020Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	447000
CY2019Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	7941000
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	9946000
CY2019Q1	us-gaap	Interest And Dividend Income Securities Available For Sale InterestAndDividendIncomeSecuritiesAvailableForSale	42000
CY2020Q1	us-gaap	Interest And Dividend Income Securities Available For Sale InterestAndDividendIncomeSecuritiesAvailableForSale	43000
CY2019Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	7490000
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	9752000
CY2019Q1	us-gaap	Interest And Fee Income Loans And Leases Held For Sale InterestAndFeeIncomeLoansAndLeasesHeldForSale	214000
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases Held For Sale InterestAndFeeIncomeLoansAndLeasesHeldForSale	1197000
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	630793000
CY2020Q1	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	644183000
CY2019Q1	us-gaap	Interest Expense InterestExpense	2841000
CY2020Q1	us-gaap	Interest Expense InterestExpense	3823000
CY2019Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2433000
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3316000
CY2019Q1	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	151000
CY2020Q1	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	260000
CY2019Q1	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	257000
CY2020Q1	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	247000
CY2019Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	5100000
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	6123000
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	5100000
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6123000
CY2019Q1	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	355000
CY2020Q1	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	107000
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	2628000
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	3624000
CY2019Q1	us-gaap	Investment Banking Revenue InvestmentBankingRevenue	124000
CY2020Q1	us-gaap	Investment Banking Revenue InvestmentBankingRevenue	151000
CY2019	us-gaap	Investment Tax Credit InvestmentTaxCredit	894000
CY2020Q1	us-gaap	Investment Tax Credit InvestmentTaxCredit	894000
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2501000
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3045000
CY2019Q4	us-gaap	Liabilities Liabilities	799881000
CY2020Q1	us-gaap	Liabilities Liabilities	862484000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	880545000
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	945365000
CY2019Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	34000
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	36000
CY2019Q4	us-gaap	Line Of Credit LineOfCredit	0
CY2019Q1	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	46000
CY2020Q1	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	97000
CY2018Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7012000
CY2019Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7024000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7138000
CY2020Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7073000
CY2019Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	670441000
CY2020Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	714941000
CY2019Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	135711000
CY2020Q1	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	115197000
CY2019Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	626000
CY2020Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1275000
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	50857000
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42188000
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13802000
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-47664000
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8366000
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34949000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	1681000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	2006000
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1707000
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1629000
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1707000
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1629000
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	115530000
CY2020Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	104322000
CY2019Q1	us-gaap	Noninterest Expense NoninterestExpense	4694000
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	7044000
CY2019Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	131000
CY2020Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	158000
CY2019Q1	us-gaap	Noninterest Income NoninterestIncome	1694000
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	3444000
CY2019Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	33000
CY2020Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	20000
CY2019Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	1452000
CY2020Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	2844000
CY2019Q1	us-gaap	Occupancy Net OccupancyNet	218000
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	253000
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	127000
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	95000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1960000
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1856000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1780000
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1685000
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2120000
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	250000
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	377000
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	536000
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	548000
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	409000
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0657
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2020Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	22579000
CY2020Q1	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	6977000
CY2019Q4	us-gaap	Other Assets OtherAssets	12254000
CY2020Q1	us-gaap	Other Assets OtherAssets	19842000
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	35000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	144000
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	35000
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	144000
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	10000
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	38000
CY2019Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	71000
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	158000
CY2019Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	81876000
CY2020Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	342138000
CY2019Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	15383000
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	42993000
CY2020Q1	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	49000
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	27000
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	5552000
CY2019Q1	us-gaap	Payments To Acquire Federal Reserve Stock PaymentsToAcquireFederalReserveStock	340000
CY2020Q1	us-gaap	Payments To Acquire Federal Reserve Stock PaymentsToAcquireFederalReserveStock	502000
CY2020Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	1000000
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	82000
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	135000
CY2019Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	243000
CY2019Q1	us-gaap	Professional Fees ProfessionalFees	288000
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	1005000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3991000
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4040000
CY2019Q4	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	6666000
CY2020Q1	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	8287000
CY2019Q4	us-gaap	Pledged Assets Separately Reported Securities Pledged For Federal Home Loan Bank At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedForFederalHomeLoanBankAtFairValue	3074000
CY2020Q1	us-gaap	Pledged Assets Separately Reported Securities Pledged For Federal Home Loan Bank At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedForFederalHomeLoanBankAtFairValue	2598000
CY2019Q4	us-gaap	Pledged Assets Separately Reported Securities Pledged For Repurchase Agreements At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedForRepurchaseAgreementsAtFairValue	1500000
CY2020Q1	us-gaap	Pledged Assets Separately Reported Securities Pledged For Repurchase Agreements At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedForRepurchaseAgreementsAtFairValue	3054000
CY2019Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-26000
CY2019Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	50000
CY2020Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	122400000
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22500000
CY2019Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1017000
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2518000
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0
CY2019Q1	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	50000
CY2019Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	73502000
CY2020Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	377294000
CY2019Q1	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	886000
CY2019Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses
CY2019Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	1000000
CY2020Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	82025000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2932000
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-926000
CY2020Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	5054000
CY2020Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears	1310000
CY2020Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears	1563000
CY2020Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear	595000
CY2020Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	793000
CY2020Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	793000
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	116000
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	143000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2020Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	1869
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	45559000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	47634000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	80664000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	82881000
CY2019Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	33788
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation
CY2003Q4	us-gaap	Subordinated Debt SubordinatedDebt	5155000
CY2019Q4	us-gaap	Subordinated Debt SubordinatedDebt	14806000
CY2020Q1	us-gaap	Subordinated Debt SubordinatedDebt	14815000
CY2019Q1	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	67000
CY2019Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.0400
CY2020Q1	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.0400
CY2019Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	41526000
CY2020Q1	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	44692000
CY2019Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.0500
CY2020Q1	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.0500
CY2019Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.1058
CY2020Q1	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.1068
CY2019Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	87857000
CY2020Q1	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	95418000
CY2019Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	62412000
CY2020Q1	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	65995000
CY2019Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.0850
CY2020Q1	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.0850
CY2019Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	58740000
CY2020Q1	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	62113000
CY2019Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.0800
CY2020Q1	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.0800
CY2019Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1197
CY2020Q1	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1229
CY2019Q1	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1	657000
CY2020Q1	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1	1404000
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	32940
CY2020Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	39562
CY2020Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	4753
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3389000
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	3465000
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	49000
CY2020Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	377000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2019Q1	us-gaap	Variable Lease Cost VariableLeaseCost	31000
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	60000
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4417775
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5400318
CY2019Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	4355748
CY2020Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5373897
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4355748
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5333947
CY2019Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock
CY2020Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	39950

Files In Submission

Name	View Source	Status
0001070680-20-000017-index-headers.html	Edgar Link	pending
0001070680-20-000017-index.html	Edgar Link	pending
0001070680-20-000017.txt	Edgar Link	pending
0001070680-20-000017-xbrl.zip	Edgar Link	pending
cfbk-20200331.xml	Edgar Link	completed
cfbk-20200331.xsd	Edgar Link	pending
cfbk-20200331x10q.htm	Edgar Link	pending
cfbk-20200331xex11_1.htm	Edgar Link	pending
cfbk-20200331xex31_1.htm	Edgar Link	pending
cfbk-20200331xex31_2.htm	Edgar Link	pending
cfbk-20200331xex32_1.htm	Edgar Link	pending
cfbk-20200331_cal.xml	Edgar Link	unprocessable
cfbk-20200331_def.xml	Edgar Link	unprocessable
cfbk-20200331_lab.xml	Edgar Link	unprocessable
cfbk-20200331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CFBK
CF BANKSHARES INC. Stock $cfbk

2020 Q1 Form 10-Q Financial Statement

#000107068020000017 Filed on May 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CFBK CF BANKSHARES INC. Stock $cfbk

2020 Q1 Form 10-Q Financial Statement

#000107068020000017 Filed on May 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CFBK
CF BANKSHARES INC. Stock $cfbk